From Reuters.

Investors were so enthusiastic about Ozempic that in 2024 its maker Novo Nordisk was the most valuable company in Europe — but this week, it lost more than 20% of its value in one day. Elena Casas explains why.

#novonordisk #ozempic #wegovy #stockmarket #pharmaceuticals #investing

Read the story here:

👉 Subscribe: http://smarturl.it/reuterssubscribe

Keep up with the latest news from around the world: https://www.reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en